Check Your Eligibility

Answer a few questions to see if you may qualify for this trial.

Step 1 of 8

Have you been tested for HLA-A*02:01 and found to be positive?

Tebentafusp is a personalized immunotherapy that only works in patients with the HLA-A*02:01 genetic marker. This test must be done before you can participate in this trial.

Show original medical criteria

HLA-A*02:01 positivity is required for tebentafusp to work, as this drug is designed to activate immune cells in patients with this specific genetic marker

This is informational only — not medical advice. Always discuss eligibility with your oncologist.